Literature DB >> 10086639

Physiology of refractory chronic constipation.

H Mertz1, B Naliboff, E Mayer.   

Abstract

OBJECTIVE: Investigators suggest three distinct pathophysiologies for patients with constipation symptoms: 1) slow colon transit, 2) irritable bowel syndrome (IBS), and 3) pelvic floor dysfunction (PFD). Our aim was to determine the prevalence of the three types of constipation pathophysiology, the degree of overlap, and what interactions exist between pathophysiologies.
METHODS: Constipated patients refractory to fiber (n = 131) underwent regional colon transit studies, anorectal manometry/EMG, measurement of rectal compliance, and rectal sensory testing. Correlations were performed examining interactions between the above measures.
RESULTS: Visceral hypersensitivity (typical of IBS) was found in 58%, slow colonic transit in 47%, PFD in 59%, and no physiological abnormalities were detected in 24%. Slow transit and visceral hypersensitivity overlapped in half of each group. PFD physiology was found in approximately half of each of the subgroups. There was no correlation between PFD physiology and rectosigmoid transit, total colon transit, or any other physiology. There were no correlations between slow transit and visceral hypersensitivity. Visceral hypersensitivity did correlate with increased rectal compliance, suggestive of increased accommodation reflexes in IBS.
CONCLUSIONS: At a tertiary center, slow transit physiology and visceral hypersensitivity typical of IBS are equally common and overlap heavily in constipated patients. PFD physiology does not correlate with slower rectosigmoid colon transit, and is seen equally in all subgroups. No abnormalities were found in 24% of patients. We therefore identify four subgroups in constipation: IBS, slow transit, both, and neither.

Entities:  

Mesh:

Year:  1999        PMID: 10086639     DOI: 10.1111/j.1572-0241.1999.922_a.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  33 in total

1.  Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial.

Authors:  Satish S C Rao; Jessica Valestin; C Kice Brown; Bridget Zimmerman; Konrad Schulze
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 2.  Management of chronic constipation in the elderly.

Authors:  Paul F Gallagher; Denis O'Mahony; Eamonn M M Quigley
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Home Biofeedback for the Treatment of Dyssynergic Defecation: Does It Improve Quality of Life and Is It Cost-Effective?

Authors:  Satish S C Rao; Jorge T Go; Jessica Valestin; John Schneider
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

Review 4.  Functional Disorders of Constipation: Paradoxical Puborectalis Contraction and Increased Perineal Descent.

Authors:  Isaac Payne; Leander M Grimm
Journal:  Clin Colon Rectal Surg       Date:  2017-02

5.  Home-based versus office-based biofeedback therapy for constipation with dyssynergic defecation: a randomised controlled trial.

Authors:  Satish S C Rao; Jessica A Valestin; Xuelian Xiang; Shaheen Hamdy; Catherine S Bradley; M Bridget Zimmerman
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-09-18

6.  Clinical utility of colonic manometry in slow transit constipation.

Authors:  S Singh; S Heady; E Coss-Adame; S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2013-02-06       Impact factor: 3.598

Review 7.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

8.  A study of anorectal manometry in patients with chronic idiopathic constipation.

Authors:  S Liu; K Zou; J Song
Journal:  J Tongji Med Univ       Date:  2000

9.  Prucalopride: the evidence for its use in the treatment of chronic constipation.

Authors:  Georges Coremans
Journal:  Core Evid       Date:  2008-06

10.  A new technique for suture rectopexy without resection for rectal prolapse.

Authors:  C A H Liyanage; G Rathnayake; K I Deen
Journal:  Tech Coloproctol       Date:  2009-03-14       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.